Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 135,246 | 30,704 | 30,845 | 38,853 | 16,829 |
| Cost of Goods | 72,248 | 17,592 | 18,537 | 18,550 | 13,325 |
| Gross Profit | 62,998 | 13,112 | 12,308 | 20,303 | 3,504 |
| Operating Expenses | 74,493 | 12,809 | 11,950 | 11,113 | 8,798 |
| Operating Income | -11,247 | 895 | 895 | 9,740 | -4,969 |
| Interest Expense | 3,796 | 547 | 564 | 272 | 214 |
| Other Income | 3,139 | 387 | 271 | 56 | 81 |
| Pre-tax Income | -11,904 | 735 | 602 | 9,524 | -5,102 |
| Income Tax | 140 | N/A | 30 | 476 | N/A |
| Net Income Continuous | -12,044 | 735 | 572 | 9,048 | -5,102 |
| Net Income | $-12,044 | $735 | $572 | $9,048 | $-5,102 |
| EPS Basic Total Ops | -0.20 | 0.01 | 0.01 | 0.16 | -0.09 |
| EPS Basic Continuous Ops | -0.20 | 0.01 | 0.01 | 0.16 | -0.10 |
| EPS Diluted Total Ops | -0.20 | 0.01 | 0.01 | 0.15 | -0.09 |
| EPS Diluted Continuous Ops | -0.20 | 0.01 | 0.01 | 0.15 | -0.10 |
| EBITDA(a) | $22,487 | $2,076 | $1,955 | $10,762 | $-3,968 |